KLRS
#3951
Kalaris Therapeutics, Inc. - Common Stock
3.9 2 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.97%
Changement Mensuel
+9.80%
Evolution sur 6 mois
-60.70%
Changement Annuel
-61.68%
Clôture Précédente
4.0 4
Open
3.9 2
Low
3.9 2
High
3.9 2
Volume
7
Financials
- Market Capitalization 93.32 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3937 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 1.01 USD | -1.94% | -1.94% | +12.22% | -58.44% | 96.04 M USD | ||
| 3941 |  RNXT RenovoRx, Inc. - Common Stock | 2.11 USD | +9.33% | +49.65% | +117.53% | +83.48% | 95.22 M USD | ||
| 3961 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.02 USD | +1.35% | -6.53% | +7.13% | -38.85% | 90.54 M USD | ||
| 3966 |  ICCC ImmuCell Corporation - Common Stock | 9.92 USD | +1.33% | +0.71% | -12.44% | +52.15% | 90.10 M USD |